Read Our Articles
Ribupatide for Weight Loss: Oral and Injectable GLP-1/GIP Results
Investigational Weight-Loss Drugs Ribupatide for Weight Loss: Oral and Injectable GLP-1/GIP Results Ribupatide is an investigational dual GLP-1/GIP receptor agonist being developed in both once-weekly injectable and once-daily oral forms for obesity and overweight. The injectable version is further along
Is Retatrutide Approved Yet? FDA Status, Availability, and Timeline
FDA Status & Drug Availability Is Retatrutide Approved Yet? FDA Status, Availability, and Timeline No. As of May 19, 2026, retatrutide is not FDA-approved for weight loss, type 2 diabetes, or any other condition. It remains an investigational once-weekly triple
CT-388 for Weight Loss: Results, Side Effects, and Current Status
Investigational Weight-Loss Drugs CT-388 for Weight Loss: Results, Side Effects, and Current Status CT-388, also called enicepatide, is an investigational once-weekly injectable GLP-1/GIP receptor agonist being developed by Roche and Genentech for obesity, type 2 diabetes, and related metabolic conditions.
GHK-Cu Copper Peptide: Benefits, Science, and Best Skincare Serums
Skin Peptides & Cosmetic Actives GHK-Cu Copper Peptide: The Complete 2026 Guide to Benefits, Science & Best Skincare Serums GHK-Cu, also called copper tripeptide-1, is a copper-binding peptide used in skincare for firmness, texture, fine lines, and skin repair support.
CT-388 vs Tirzepatide: How Roche’s GLP-1/GIP Drug Compares
Drug Comparison CT-388 vs Tirzepatide: How Roche’s GLP-1/GIP Drug Compares CT-388 and tirzepatide are both once-weekly injectable GLP-1/GIP receptor agonists, but they are not at the same evidence stage. Tirzepatide is FDA-approved for chronic weight management under the Zepbound brand,
VK2735 for Weight Loss: Oral GLP-1/GIP Results and Current Status
Investigational Weight-Loss Drugs VK2735 for Weight Loss: Oral GLP-1/GIP Results and Current Status VK2735 is an investigational dual GLP-1/GIP receptor agonist being studied for weight loss in both oral and injectable forms. The oral tablet has shown meaningful short-term weight
MariTide for Weight Loss: Monthly Injection, Results, and Current Status
Investigational monthly weight-loss injection guide By VerifiedSupps Editorial Team MariTide for Weight Loss: Monthly Injection, Results, and Current Status MariTide is an investigational long-acting weight-loss medication designed for monthly or less frequent injection. In Phase 2, it produced substantial weight
Mazdutide for Weight Loss: Results, Side Effects, and How It Works
GLP-1 plus glucagon weight-loss medication guide By VerifiedSupps Editorial Team Mazdutide for Weight Loss: Results, Side Effects, and How It Works Mazdutide is a once-weekly GLP-1/glucagon dual receptor agonist that has shown meaningful weight-loss results in Chinese clinical trials. It
Pemvidutide for Weight Loss and Fatty Liver: Results, Side Effects, and Current Status
Investigational GLP-1 plus glucagon liver and weight-loss guide By VerifiedSupps Editorial Team Pemvidutide for Weight Loss and Fatty Liver: Results, Side Effects, and Current Status Pemvidutide is an investigational once-weekly injectable GLP-1/glucagon dual receptor agonist being studied for obesity, metabolic
DSIP Peptide: Sleep, Stress, and What the Evidence Actually Shows
Investigational sleep peptide evidence review By VerifiedSupps Editorial Team DSIP Peptide: Sleep, Stress, and What the Evidence Actually Shows DSIP, short for delta sleep-inducing peptide, sounds like a direct answer for poor sleep. The evidence is much less direct: human
Cagrilintide for Weight Loss: The Amylin Peptide Behind CagriSema
Investigational amylin peptide weight-loss guide By VerifiedSupps Editorial Team Cagrilintide for Weight Loss: The Amylin Peptide Behind CagriSema Cagrilintide is an investigational long-acting amylin analogue being studied for weight management. It matters because it is the amylin component inside CagriSema,
CagriSema for Weight Loss: Results, Setbacks, and Current Status
Investigational GLP-1 plus amylin weight-loss medication guide By VerifiedSupps Editorial Team CagriSema for Weight Loss: Results, Setbacks, and Current Status CagriSema is an investigational once-weekly injectable combination of cagrilintide, an amylin analogue, and semaglutide, a GLP-1 receptor agonist. In Phase